An image from Cytex’s research on its proprietary implant was featured on the December 2016 cover of Bonezone, an Orthoworld publication focused on commercialization solutions for the orthopedic industry.
Cytex’s 3-D weave technology is featured as this fall’s cover image on the Regenerative Medicine issue of Breakthroughs in Bioscience, a journal highlighting scientific breakthroughs important to society. The publication is produced by Federation of American Societies for Experimental Biology (FASEB), the nation’s largest coalition of biomedical researchers.
Cytex is thrilled to receive an award from NIH to fund strategic regulatory and manufacturing planning to accelerate the commercialization of its products. The grant awarded is part of the pilot Commercialization Readiness Program offered to recipients of NIH Phase II SBIR/STTR awards.
Cytex is delighted to be awarded entry to the highly successful Commercialization Acceleration Program offered as a competitive award to recipients of NIH Phase II SBIR or STTR awards. The program provides training and support for Cytex staff in commercialization activities such as regulatory planning, investment negotiations, and product marketing.
Cytex is honored to have an image of its resurfacing scaffold selected for the cover image of the Spring-Summer 2016 edition of Science Editor.
Cytex’s intellectual portfolio continues to strengthen with the latest patent issued, “Tissue Engineering Methods and Composition,” in Canada on June 21, 2016.
Cytex’s technology, as published in the latest Proceedings of the National Academy of Sciences, is making a splash worldwide. Cytex’s scientists and cartilage resurfacing technology was featured in U.S. News and World Report Health News, The Huffington Post, Health, Yahoo News, and dozens of other news outlets in response to the recently published study in […]
Cytex’s VP of Research and Development, Dr. Brad Estes and Dr. Farsh Guilak, Professor of Orthopaedic Surgery at Washington University and Cytex’s President, co-led a team of researchers in a study published July 18, 2016 in the prestigious journal PNAS. Results from this study highlighted Cytex’s tissue engineered implants’ cartilage-like properties, ability to maintain complex […]
The ORS hosts the premier orthopaedic research conference for basic science and clinical researchers in the United States. Dr. Moutos presented findings from cutting-edge research in a talk entitled “Anatomically Shaped Tissue-Engineered Cartilage with Tunable and Inducible Anti-Cytokine Delivery for Biological Joint Resurfacing.”
Cytex is thrilled to add the expertise of Dr. Vincent P. Willard to our talented team. Dr. Willard brings over 14 years of research experience in molecular and stem cell biology, orthopaedic tissue engineering, and gene therapy to Cytex. He will serve as the Director of Regenerative Therapies.